MIR1229 Gene

HGNC Family Non-coding RNAs
Name microRNA 1229
Description microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nRecent studies have revealed that miR‑1229, including its mature isoform miR‑1229‑3p, is up‑regulated in several human cancers and functions predominantly as an oncogenic microRNA. In colorectal cancer, elevated circulating exosomal miR‑1229 levels correlate with tumor size, lymphatic metastasis, advanced stage and poor survival, acting in part through suppression of HIPK2 to activate the VEGF pathway and promote angiogenesis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " Moreover, in breast cancer, increased miR‑1229 expression stimulates malignant cell proliferation via activation of the Wnt/β‑catenin signaling cascade—achieved by targeting multiple negative regulators such as APC, GSK‑3β and ICAT—while in head and neck squamous cell carcinoma and hepatocellular carcinoma, miR‑1229‑3p overexpression is associated with enhanced tumor progression and serves as an independent prognostic marker."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "3", "end_ref": "5"}]}, {"type": "t", "text": " In addition, the diagnostic potential of circulating miR‑1229 has been demonstrated in colorectal cancer, further emphasizing its clinical relevance."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nmiR‑1229‑3p is also a pivotal downstream effector in competing endogenous RNA networks. For instance, in glioma, the oncogenic role of miR‑1229‑3p is unleashed when its activity is de‑repressed by the sponging activity of circ_0037251, resulting in the up‑regulation of mTOR and increased tumor aggressiveness."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": " Similarly, in breast cancer, the tumor‑suppressive circ_0000442 exerts its function by binding miR‑1229‑3p, which in turn leads to an increase in ZBTB1 expression and inhibition of malignant behaviors."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": " A comparable mechanism has been observed in gastric cancer, where decreased levels of circ_0005758 result in miR‑1229‑3p‑mediated down‑regulation of GCNT4, thereby promoting oncogenic processes."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond oncogenesis, the structure and processing of pre‑miR‑1229 have been implicated in Alzheimer’s disease pathology. A disease‑associated single nucleotide polymorphism in pre‑miR‑1229 shifts the equilibrium between a G‑quadruplex conformation and the canonical hairpin structure, subsequently altering the production of mature miR‑1229‑3p. This change is thought to affect the translation of SORL1, a protein important for amyloid precursor protein processing, and may represent a novel therapeutic avenue in Alzheimer’s disease."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "10"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Zhanyao Tan, Haiqing Zheng, Xiangxia Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-1229 overexpression promotes cell proliferation and tumorigenicity and activates Wnt/β-catenin signaling in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.8119"}], "href": "https://doi.org/10.18632/oncotarget.8119"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26992223"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26992223"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Hui-Ying Hu, Chen-Huan Yu, Huan-Huan Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Exosomal miR-1229 derived from colorectal cancer cells promotes angiogenesis by targeting HIPK2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Biol Macromol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ijbiomac.2019.03.221"}], "href": "https://doi.org/10.1016/j.ijbiomac.2019.03.221"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30936013"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30936013"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Keiji Nishibeppu, Shuhei Komatsu, Taisuke Imamura, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Plasma microRNA profiles: identification of miR-1229-3p as a novel chemoresistant and prognostic biomarker in gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-020-59939-8"}], "href": "https://doi.org/10.1038/s41598-020-59939-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32081926"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32081926"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Xinyuan Zhao, Li Cui "}, {"type": "b", "children": [{"type": "t", "text": "A robust six-miRNA prognostic signature for head and neck squamous cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Physiol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcp.29723"}], "href": "https://doi.org/10.1002/jcp.29723"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32342519"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32342519"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Chunhong Zhang, Qi Zhang, Honghai Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-1229-3p as a Prognostic Predictor Facilitates Cell Viability, Migration, and Invasion of Hepatocellular Carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Horm Metab Res (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1055/a-1646-8415"}], "href": "https://doi.org/10.1055/a-1646-8415"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34740278"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34740278"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Reihaneh Rafiee, Ehsan Razmara, Mahsa Motavaf, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circulating serum miR-1246 and miR-1229 as diagnostic biomarkers in colorectal carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cancer Res Ther (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4103/jcrt.JCRT_752_20"}], "href": "https://doi.org/10.4103/jcrt.JCRT_752_20"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36510992"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36510992"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Qinchen Cao, Yonggang Shi, Xinxin Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circular METRN RNA hsa_circ_0037251 Promotes Glioma Progression by Sponging miR-1229-3p and Regulating mTOR Expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-019-56417-8"}], "href": "https://doi.org/10.1038/s41598-019-56417-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31875034"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31875034"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Jingyu Liu, Jianhui Liu "}, {"type": "b", "children": [{"type": "t", "text": "Circ_0000442 functions as a tumor repressor in breast cancer by impacting miR-1229-3p and upregulating ZBTB1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mamm Genome (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00335-022-09950-3"}], "href": "https://doi.org/10.1007/s00335-022-09950-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35394175"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35394175"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Peiyuan Li, Weisheng Xiao "}, {"type": "b", "children": [{"type": "t", "text": "Circ_0005758 impedes gastric cancer progression through miR-1229-3p/GCNT4 feedback loop."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Toxicol In Vitro (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.tiv.2022.105454"}], "href": "https://doi.org/10.1016/j.tiv.2022.105454"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35970245"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35970245"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Joshua A Imperatore, McKenna L Then, Keefe B McDougal, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Characterization of a G-Quadruplex Structure in Pre-miRNA-1229 and in Its Alzheimer's Disease-Associated Variant rs2291418: Implications for miRNA-1229 Maturation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Sci (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/ijms21030767"}], "href": "https://doi.org/10.3390/ijms21030767"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31991575"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31991575"}]}]}]}
Synonyms HSA-MIR-1229, MIRN1229
NCBI Gene ID 100302156
API
Download Associations
Predicted Functions View MIR1229's ARCHS4 Predicted Functions.
Co-expressed Genes View MIR1229's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View MIR1229's ARCHS4 Predicted Functions.

Functional Associations

MIR1229 has 745 functional associations with biological entities spanning 4 categories (molecular profile, functional term, phrase or reference, cell line, cell type or tissue, gene, protein or microRNA) extracted from 12 datasets.

Click the + buttons to view associations for MIR1229 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR1229 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR1229 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR1229 gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR1229 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of MIR1229 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
GeneSigDB Published Gene Signatures PubMedIDs of publications reporting gene signatures containing MIR1229 from the GeneSigDB Published Gene Signatures dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of MIR1229 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR1229 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles cell lines with high or low expression of MIR1229 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset.
KnockTF Gene Expression Profiles with Transcription Factor Perturbations transcription factor perturbations changing expression of MIR1229 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of MIR1229 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR1229 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.